Bosh sahifaBSX • NYSE
add
Boston Scientific Corporation
90,21 $
Dastlabki sotuv:(0,86%)+0,78
90,99 $
Yopilgan:27-noy, 0:09:45 (GMT-5) · USD · NYSE · Ogohlantirish
Yopilish kursi
89,25 $
Kunlik diapazon
89,10 $ - 90,39 $
Yillik diapazon
53,93 $ - 91,93 $
Bozor kapitalizatsiyasi
134,07 mlrd USD
Oʻrtacha hajm
6,92 mln
Narx/foyda
74,57
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 4,21 mlrd | 19,34% |
Joriy xarajat | 2,17 mlrd | 20,38% |
Sof foyda | 469,00 mln | -7,13% |
Sof foyda marjasi | 11,14 | -22,21% |
Har bir ulushga tushum | 0,63 | 26,00% |
EBITDA | 1,02 mlrd | 12,65% |
Amaldagi soliq stavkasi | 29,90% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 2,50 mlrd | 162,82% |
Jami aktivlari | 38,08 mlrd | 11,85% |
Jami passivlari | 17,12 mlrd | 14,80% |
Umumiy kapital | 20,96 mlrd | — |
Tarqatilgan aksiyalar | 1,47 mlrd | — |
Narxi/balansdagi bahosi | 6,35 | — |
Aktivlardan daromad | 4,77% | — |
Kapitaldan daromad | 5,63% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 469,00 mln | -7,13% |
Operatsiyalardan naqd pul | 1,00 mlrd | 43,55% |
Sarmoyadan naqd pul | -1,43 mlrd | -624,37% |
Moliyadan naqd pul | 7,00 mln | -56,25% |
Naqd pulning sof oʻzgarishi | -412,00 mln | -180,31% |
Boʻsh pul | 612,38 mln | 43,29% |
Haqida
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Wikipedia
Tashkil etilgan
29-iyn, 1979
Xodimlar soni
48 000